Business Context and Reporting Period
Company: Acacia Research Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1997
Business Overview: The Company provides investment advisory and management services to emerging corporations and makes direct investments. It holds significant economic interests in five companies (Whitewing Labs, MerkWerks, CombiMatrix, Soundview Technologies, and Greenwich Information Technologies) and acts as a general partner in two private investment partnerships.
Key Financial Metrics
| Metric | Q1 1997 | Q1 1996 |
|---|---|---|
| Revenues (Net) | $(20,935) | $1,826,117 |
| Net (Loss) Income | $(1,011,412) | $879,790 |
| EPS (Primary/Basic) | $(0.50) | $0.34 |
| Cash and Cash Equivalents | $442,533 | $873,375 |
| Working Capital | $529,330 | Filing text does not provide a clear value |
| Total Assets | $5,066,300 | Filing text does not provide a clear value |
| Total Liabilities | $1,301,828 | Filing text does not provide a clear value |
| Notes Payable | $450,000 | Filing text does not provide a clear value |
Material Changes vs. Prior Period
- Revenue Collapse: Net revenues swung from a profit of $1.83 million in Q1 1996 to a loss of $20,935 in Q1 1997. This is primarily due to the absence of a $1.07 million non-cash unrealized gain from a Whitewing Labs stock issuance in the prior year and a drop in gains on securities sales from $552,366 to $50,000.
- Legal Settlement Expense: The Company recorded a one-time charge of $460,000 for a legal settlement with former director Ann P. Hodges. No such expense existed in the prior period.
- Investment Losses: Equity earnings from investments turned negative, reporting a loss of $117,257 compared to earnings of $173,202 in the prior year. This was driven by losses in Whitewing Labs and Greenwich Information Technologies.
- Operating Expenses: Marketing, general, and administrative expenses increased to $571,384 from $425,781, attributed to increased personnel costs and litigation-related expenses.
- Liquidity: Cash and cash equivalents increased by $266,282 during the quarter, ending at $442,533, despite the net loss. This was supported by $400,000 in distributions received from partnerships and $216,610 in proceeds from the sale of common stock.
Guidance, Outlook, and Risks
- Capital Needs: Management anticipates that current working capital and operating revenues may fund expenses in the foreseeable future but may seek additional financing (equity or debt) for new opportunities. There is no assurance that funding will be available on favorable terms.
- Debt Obligations: The Company has a $450,000 note payable to Greenwich Information Technologies LLC, secured by a pledge of membership interest. Monthly payments range from $25,000 to $50,000, with the final payment due in December 1997. Default could result in the loss of a substantial portion of the membership interest.
- Legal Contingency: The $460,000 settlement with the Hodges includes a provision where the Company must make a cash payment if the plaintiffs do not realize $475,000 in profits from stock options granted as part of the settlement.
- Forward-Looking Statements: The filing includes standard disclaimers regarding uncertainties in future economic conditions, regulatory developments, and the ability to manage growth.
Investor Verification Checklist
- Legal Settlement Terms: Verify the specific vesting schedule and profit thresholds for the stock options granted to the Hodges to assess potential future cash outflows.
- Debt Service Capacity: Confirm the Company's ability to meet the $25,000–$50,000 monthly principal payments on the Greenwich Information Technologies note through December 1997.
- Investment Portfolio Performance: Review the specific financial performance of Whitewing Labs and Greenwich Information Technologies, which drove the equity investment losses.
- Revenue Sustainability: Assess the trajectory of management fee income ($32,202 in Q1 1997) to determine if it can offset operating expenses without reliance on asset sales.
- Stock Issuance: Verify the terms and dilution impact of the common stock sold for $216,610 during the quarter.